Association of miltefosine with granulocyte and macrophage colony-stimulating factor (GM-CSF) in the treatment of cutaneous leishmaniasis in the Amazon region: A randomized and controlled trial.

MLA

Mendes, Luciana, et al. “Association of Miltefosine with Granulocyte and Macrophage Colony-Stimulating Factor (GM-CSF) in the Treatment of Cutaneous Leishmaniasis in the Amazon Region: A Randomized and Controlled Trial.” International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases, vol. 103, Feb. 2021, pp. 358–63. EBSCOhost, https://doi.org/10.1016/j.ijid.2020.11.183.

APA

Mendes, L., Guerra, J. O., Costa, B., Silva, A. S. da, Guerra, M. das G. B., Ortiz, J., Doria, S. S., Silva, G. V. da, de Jesus, D. V., Barral-Netto, M., Penna, G., Carvalho, E. M., & Machado, P. R. L. (2021). Association of miltefosine with granulocyte and macrophage colony-stimulating factor (GM-CSF) in the treatment of cutaneous leishmaniasis in the Amazon region: A randomized and controlled trial. International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases, 103, 358–363. https://doi.org/10.1016/j.ijid.2020.11.183

Chicago

Mendes, Luciana, Jorge Oliveira Guerra, Bleno Costa, Aríneia Soares da Silva, Maria das Graças Barbosa Guerra, Jéssica Ortiz, Susan Smith Doria, et al. 2021. “Association of Miltefosine with Granulocyte and Macrophage Colony-Stimulating Factor (GM-CSF) in the Treatment of Cutaneous Leishmaniasis in the Amazon Region: A Randomized and Controlled Trial.” International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases 103 (February): 358–63. doi:10.1016/j.ijid.2020.11.183.